TABLE 1

Demographic Characteristics of Patients Undergoing 18F-Fluciclovine Versus 68Ga-PSMA-11 for Prostate Cancer and Results of Multivariate Regression Analysis

Characteristic18F-fluciclovine68Ga-PSMAOdds ratioP
All patients2541,502
Age (mean ± SD)69.8 ± 7.969.6 ± 7.71.01 (0.99–1.04)0.097
Body mass index (mean ± SD)28.1 ± 4.027.7 ± 4.51.00 (0.97–1.04)0.761
Race
 Non-Hispanic White182 (71.6%)1201 (80.0%)1.00
 Black or African American17 (6.7%)24 (1.6%)3.88 (1.90–7.91)<0.001
 Hispanic13 (5.1%)45 (3.0%)1.79 (0.84–3.81)0.131
 Asian American or Native Hawaiian/other Pacific Islander22 (8.7%)87 (5.8%)1.64 (0.95–2.85)0.073
 Unknown20 (7.9%)145 (9.6%)1.06 (0.55–2.02)0.87
Preferred language
 English246 (96.9%)1474 (98.1%)1.00
 Not English8 (3.1%)28 (1.9%)1.29 (0.53–3.13)0.581
Insurance type
 Commercial87/238 (36.6%)478 (31.8%)1.00
 Government149/238 (62.6%)929 (61.9%)0.70 (0.48–1.01)0.06
 Unknown2/238 (0.8%)95 (6.3%)0.39 (0.09–1.73)0.215
nSES
 Highest tertile143/235 (60.9%)855/1,263 (67.7%)1.00
 Middle tertile67/235 (28.5%)303/1,263 (24.0%)1.27 (0.89–1.81)0.194
 Lowest tertile25/235 (10.6%)105/1,263 (8.3%)1.08 (0.62–1.91)0.78
  • *For any categories in which demographic information was missing from patient records, new denominator is noted (insurance type and nSES).

  • Data in parentheses are percentage or 95% CI.